This post contains affiliate links, which means the website may earn a small commission at no extra cost to you if you make a purchase through them. The HerHealth101 team only recommends products that align with our mission to support women’s health, and is not a reflection of any specific author. Your support helps keep this site growing. Thank you!
Writing about breast cancer feels personal for so many of us because it is a diagnosis that has touched almost every family in some way. We’ve seen the ribbons, and heard the stories, but when it happens to you or a loved one, it hits differently. Understanding what is actually happening in the body and what can be done about it can take some of the power back from the fear of the unknown.
What is Breast Cancer?
At its most basic level, breast cancer occurs when cells in the breast begin to grow out of control. These cells usually form a tumor that can often be seen on an X-ray or felt as a lump. While we often think of it as one single disease, it is actually a collection of different types of cancer that all originate from the breast.
Understanding the Types
Two common types of breast cancer you’ll hear about are Ductal Carcinoma in Situ (DCIS) and Invasive Ductal Carcinoma (IDC). The term “in situ” means “in its original place”, so you can think of DCIS as a cancer whose abnormal cells are still contained within the milk ducts. Think of DCIS as a pre-invasive, and has not spread to other tissues, so the prognosis is excellent because these can usually be prevented from becoming more serious. Invasive carcinoma is when those abnormal cells have broken through the duct walls and started to move into the surrounding breast tissue. The problem with this is that the surrounding tissue contains blood vessels and lymphatic channels, and if the cancer cells make it to either of them, they can now spread to other parts of the body, beyond the breast, which we call metastasis.
IDC is the most common type of cancer, making up about 80% of all diagnosis. And a diagnosis of DCIS, while not life-threatening at that stage, has an estimated 30% chance of becoming invasive if left untreated.
A third type of breast cancer is called Invasive Lobular Carcinoma, which is a cancer that starts in the lobules of the breast, which are the glands that produce milk. And less common types of breast cancer include Inflammatory Breast Cancer, a rare but aggressive cancer, and Piaget’s Disease of the Breast.
Risk Factors
When we look at risk factors, age is a significant one, as the risk increases as we get older. Genetics play a huge role too, specifically mutations in the BRCA1 and BRCA2 genes, but it’s important to remember that most people diagnosed with breast cancer have no family history at all.
Another consideration in risk assessment is the amount of estrogen and progesterone breast cells have been exposed to. This is because breast cells are highly sensitive to these hormones which tell the cells to divide and grow, and the more cycles this happens, the higher the statistical chance that a mistake or mutation will occur. This is why factors such as starting your period at a very young age (before age 12), late menopause (after age 55), or never having been pregnant are considered small contributors of risk, because those women have had longer exposure to the hormones made by their ovaries.
Given the effect that estrogen and progesterone have on breast tissue, you may wonder about the effects of hormonal birth control. Well, this is a nuanced topic, but the general consensus is that many of the protective trade-offs of them, outweighs the risk of breast cancer. Statistically speaking, current research has shown that for every 7,700 women who use hormonal contraception, there is roughly one additional case of breast cancer. Furthermore, once the birth control is stopped, that elevation fades and your risk returns to the same levels as if you never used it. And the trade-off for that slight increase in risk of breast cancer, hormonal birth control significantly lowers the risk of ovarian, endometrial and colorectal cancers.
The risk of using hormone replacement therapy (HRT), usually in women during menopause, is a bit more complicated because it is usually taken later in life when the baseline risk is naturally higher, but also can differ based on types of hormones given, whether the hormones are bioidentical vs synthetic, or if they’ve had a hysterectomy. Generally speaking, topical estrogen has minimal effects, but if you are a woman with a higher predisposition for breast cancer, it is worth a conversation with your doctor before starting systemic HRT.
How Does Breast Cancer Present? Lump vs No Lump
Most people know to look for a lump, but breast cancer can be a bit more subtle than that. While a manual breast exam is still generally recommended after age 25 (though no longer a rigid guideline by the American Cancer Society), it’s important to know that not all cancers present with a lump. It can present as a change in the shape or size of the breast, skin dimpling that looks like an orange peel, a nipple that starts to turn inward, or even persistent redness or scaling. There has been a recent shift towards ‘breast self-awareness’, meaning knowing what is normal for your body, so that you can immediately report any changes in your breast tissue to your doctor for evaluation.
The Power of the Mammogram
Since mammograms became widespread in the late 1980s and 1990s, breast cancer deaths have dropped in the US by 40% due to early detection. That’s huge! The mammogram is a low-dose X-ray that allows us to see subtle changes in the breast tissue long before they can be felt by you or your doctor, which means we can catch things at a stage where they are much easier to treat.
Current guidelines suggest that most women should begin annual or biennial (every 2 years) screenings at age 40, because it is estimated that one in six breast cancers occur in women in their 40s, and for Asian, Black and Hispanic women, one third of all breast cancers are diagnosed under the age of 50.
If you are a woman with a known genetic mutation (like BRCA) or a strong family history of breast cancer, some doctors may recommend annual screenings starting as early as age 25 or 30.
Diagnosis, Grading, and Staging
If something suspicious is found, the next step is usually a biopsy. This is where we look at the cells to see how aggressive they look, which is then given a ‘grade’. A low grade means the cells look somewhat like normal breast cells, while a high grade means they look very disorganized and are likely growing faster.
If the cells appear abnormal, the cancer is then given a ‘Stage’, which is determining how far the cancer has traveled.
- Stage 0 is non-invasive (like DCIS).
- Stages I through III involve the breast tissue, and is determined by size and sometimes involvement of nearby lymph nodes.
- Stage IV means the cancer has moved to other parts of the body.
A more detailed staging system is called the ‘TNM System’ which your doctor may use to better understand the exact cancer situation by assigning values to tumor size (T), lymph node involvement (N) or if it has metastasized (M).
In 2026, it has also become routine to test for biomarkers such as ER/PR and HER2, because these results can let us know if your particular type of cancer will respond better to certain medications or not, and thus help us determine the best treatment option to take. If none of the three biomarkers are present, the cancer may be referred to as ‘triple negative breast cancer’ (TNBC).
Treating Breast Cancer
Treatment today is incredibly tailored to the individual. It isn’t a one-size-fits-all approach anymore. With so many variations in types of breast cancer, size, spread and biomarkers, the treatment plan may consist of one or multiple methods to slow down, remove or even reverse the cancer.
- Surgery: This could be a lumpectomy (removing just the tumor) or a mastectomy (removing the breast tissue).
- Radiation: High-energy waves are used to target and kill any remaining cancer cells in the breast area after surgery.
- Chemotherapy: These are powerful medications that travel through the whole body to kill fast-growing cells.
- Hormone Therapy: Many breast cancers are fueled by estrogen or progesterone (ER/PR positive). If yours is “hormone receptor-positive,” we can use medications to block those hormones and starve the cancer cells.
- Targeted and Genetic Therapy: We now have drugs that can target specific proteins on the cancer cells, like HER2, which has revolutionized the prognosis for many women.
This is why early detection is so important. If a mammogram is able to catch a cancer at a localized stage, the 5 year survival rate is 99%. And the treatment plan can be more targeted, less aggressive and have better outcomes. With the advances in modern medicine, there are even long-term treatments available that can even allow women with certain stage IV cancers to live high-quality lives for many years.
Breast Cancer in Men
While it is much rarer, it is important to bring up the topic of breast cancer in men. Men do have breast tissue, and that tissue can develop cancer just like it does in women. In 2026, it is estimated that about 2,670 men in the U.S. will be diagnosed with invasive breast cancer, and because there is no routine screening like mammograms for men, these cases are often caught at a more advanced stage. The most common sign is a painless lump behind the nipple or areola, but it can also present as nipple inversion or skin changes. Genetics play a massive role here, specifically, men with a BRCA2 mutation have a lifetime risk of up to 7%, which is significantly higher than the average male risk of about 0.1%. Other factors like Klinefelter syndrome, liver disease, or a family history of breast cancer can also tilt the scales. Because the majority of male breast cancers are highly estrogen-receptor positive, they often respond very well to hormone therapies, but the key is catching it early by not ignoring a lump just because of a gendered misconception about the disease.
Preventing Breast Cancer
While we cannot control our genetics or the passage of time, there is an incredible amount of power in the lifestyle choices we make every single day. One of the most impactful things we can do is maintain a healthy weight, especially after menopause, because fat tissue becomes a primary source of estrogen production in our later years. Pairing this with regular physical activity, even just a brisk thirty minute walk most days, helps regulate our hormone levels and keeps the immune system sharp. When it comes to alcohol, even moderate drinking is linked to an increased risk, as is smoking, so eliminating or minimizing those behaviors can not only reduce breast cancer, but improve overall health. And for those who have the opportunity, breastfeeding for a year or more can also offer a protective biological benefit by maturing the breast cells and reducing the total number of menstrual cycles.
For women who carry a BRCA mutation, prevention moves from general lifestyle habits into a much more proactive, high-stakes medical strategy. Because these mutations significantly hinder the body’s ability to repair DNA damage, the risk of developing breast cancer is substantially higher, which often leads to a “surveillance-plus” approach. This usually involves intensive screening starting as early as age 25, utilizing annual breast MRIs alongside mammograms to catch any changes at the earliest possible micro-level. For many, the conversation eventually turns toward risk-reducing surgeries, such as a prophylactic bilateral mastectomy, which can reduce the risk of developing breast cancer by over 90 percent. There is also the option of chemoprevention, using medications like tamoxifen or raloxifene to block estrogen and lower the likelihood of hormone-sensitive tumors forming. Navigating these choices is deeply personal and often feels like a heavy weight to carry, but having this genetic knowledge is actually a powerful gift. It allows us to be several steps ahead of the disease, making decisions from a place of empowerment rather than reacting to a crisis.
Final Thoughts
Talking about breast cancer is about so much more than just a medical diagnosis; it is about reclaiming a part of our lives that often feels inextricably linked to our sense of womanhood and identity. For a long time, this was a topic whispered about in shadows, but the landscape of breast cancer has shifted dramatically over the last few decades. We have moved from a time when a diagnosis was met with limited, often aggressive options, to a modern era where early detection and personalized, targeted therapies have turned the tide on prognosis for millions of women. However, we cannot let that progress lead to complacency. We need to keep spreading awareness and deep, accessible education because knowledge is the literal difference between fear and action. By understanding our bodies and the science behind the screening, we empower ourselves to catch this condition when it is most treatable, ensuring that we save as many lives as possible and prevent this disease from defining who we are.
